Overview | Agenda/Faculty Materials | Promotional Opportunities | Brochure
Speaking Proposals | Order CDs | Administration | Past Conferences | Contact Us | Home


Fundamental changes in the regulations applied to the pharmaceutical industry, public opinion on standards of ethical behavior and the global economic situation make this a challenging time to be a compliance professional or legal counsel responsible for ensuring adherence to applicable laws, regulations and codes of practice within our industry.

The PCF International Pharma Congress brings together senior global compliance professionals and legal counsel from around the world to share experiences and best practices to clarify these changes and potential responses to them. In Europe, the new Pharma Package (which focuses on three key areas: anti-counterfeiting initiatives, pharmacovigilance and providing information for patients) was finally adopted in December 2008. In the USA, the newly revised PhRMA code and the new Obama administration are beginning to have a significant impact across the pharmaceutical industry. In Asia, governments are bringing in new legislation and / or enforcing existing legislation to dispel perceptions of corruption and / or conflicts of interest within the public sector.

Keynote speakers representing the IFPMA, European Commission and Patients will give their views on the changes affecting our industry and how pharmaceutical companies can make a real difference during these challenging times. Panel discussions will focus on transparency and international compliance. There will also be smaller track discussions on the new European Pharma Package, clinical trials in emerging markets and a selection of case study sessions.

If you want to find out how to manage compliance in these challenging times, the PCF International Pharma Congress will give you the information that you need.

  • Pharmaceutical Manufacturers
  • Generic Pharmaceutical Manufacturers
  • Site Management Organizations
  • Clinical Research Organizations
  • Management Companies
  • Wholesale, Retail, Mail Order and Internet Pharmacies
  • Health Care Regulators and Policy Makers
  • Pharmaceutical and Health Care Executives and Board Members
  • Regulatory and Compliance Professionals
  • Medical Directors
  • Physicians
  • Pharmacists

  • Food and Drug Law Attorneys
  • Health Care Attorneys and In-house Counsel
  • Compliance Officers
  • Privacy Officers
  • Ethics Officers and Corporate Social Responsibility Personnel
  • Pharmaceutical Consultants
  • Investment Bankers
  • Venture Capitalists
  • Health Services Researchers and Academics
  • Auditors
  • Promotion Signatories/Approvers
  • Risk Management Personnel

Pharmaceutical Compliance Forum:

The Pharmaceutical Compliance Forum (PCF), www.PharmaComplianceForum.org, is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs. The members meet twice a year, for two days, focusing on open and informal sharing of compliance information, best practices, and current developments in the field, and sponsors a two-day international compliance congress in the Spring and a three-day US compliance congress each Fall. For membership information, contact Colleen Lacey at 215-599-6617 or via email at info@PharmaComplianceForum.org.

Pierre E. Dupourque
Regional Compliance Director, Corporate Compliance, International Investigations & Programs, Pfizer Inc.

Sue Egan (Co chair)
Vice President Compliance, AstraZeneca

Lori Queisser (Co chair)
Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation

Roeland van Aelst (Co chair)
Executive Director, Health Care Compliance, Europe, Middle East Africa, Johnson & Johnson

Ted Acosta, Esq.
Principal, Ernst & Young LLP

John T. Bentivoglio, Esq.
Partner, King & Spalding LLP

Kathleen Boozang, Esq.
Associate Dean for Academic Affairs, Cofounder, Health Law & Policy Program, and Health Law, Science and Technology Graduate Programs, Seton Hall Law School

Ian Dodds-Smith, Esq.
Partner, Arnold & Porter LLP

Pierre E. Dupourque
Regional Compliance Director, Corporate Compliance, International Investigations and Programs, Pfizer Inc.

Michael Fadus
Compliance Director, Central & Eastern Europe at Schering-Plough Corporation

Gerard Geneen
Compliance Officer, Pharma Europe, GlaxoSmithKline

Linda Horton, Esq.
Partner, Hogan & Hartson LLP

Georgia Keresty
Senior Vice President Pharmaceutical Compliance and Global Regulatory Affairs, Johnson & Johnson

Jonathon L. Kellerman
Partner, Pharmaceutical and Life Sciences Practice, PricewaterhouseCoopers LLP

Keith M. Korenchuk, JD, MPH
Of Counsel, Covington & Burling LLP

Dominique Laymand
Senior Director Compliance, Bristol-Myers Squibb

Maurits J.F. Lugard, MA, JD, LLM
Partner, Sidley Austin LLP

Maxine Nogard
International Compliance Officer, Wyeth

Dave O'Shaunessy
Compliance Officer, Pharmaceuticals International, GlaxoSmithKline

Michael Shaw
Global Head, Ethics & Compliance, Novartis Oncology

Paul B. Woods, BPharm, MA, MRPharmS
Global Compliance Policy Director, AstraZeneca

Overview | Agenda/Faculty Materials | Promotional Opportunities | Brochure
Speaking Proposals | Order CDs | Administration | Past Conferences | Contact Us | Home

© Health Care Conference Administrators
Contact Webmaster